Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
Blog
The Difference Between Specialty Drugs, Biologics, and Biosimilars
In the world of workers’ comp pharmacy benefit management, understanding generics vs.
WorkCompWire
Article
40 Years in Workers' Comp: Looking back on Our Industry's Continuous Evolution
This month Genex Services is celebrating its 40th anniversary, a significant accomplishment in this industry.
Workers' Comp
Article
CMS Releases Version 2.8 of WCMSA Reference Guide
Keep current with new legislation and its potential effect on your organization.
Mitchell
News Release
Florida Issues State of Emergency for Hurricane Michael
The state of Florida has issued a state of emergency in preparation for Hurricane Michael.
Workers' Comp
Blog
Topical Trend Differences: Understanding Drug Mix
Topical medication cost and utilization continue to decrease in the managed population.
Workers' Comp
Article
Making the Case for Nurse Case Managers
Nurse case managers play an influential role in an